Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.

The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Novartis taps MOOC technology to share chemistry education with the world

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.

Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research